Transcriptions
Note: this content has been automatically generated.
00:00:00
Is it a problem. So possibly biotech
00:00:02
company currently in incorporates. So
00:00:06
you all know funky I guess. P edible
00:00:08
room mate you have four Nice or the the
00:00:13
that most probably in your problem. But
00:00:16
one can do other things. They can make
00:00:18
you read or one you make it speaker if
00:00:22
the so there are around one point five
00:00:24
million species upon onion or I maybe a
00:00:28
subset hundred of those are can cause
00:00:32
severe a these to human especially if
00:00:36
you compromised stations. So if you
00:00:38
look at cancer or transplant patients
00:00:42
or have a lot of American sees the
00:00:44
immune system is compromised the spongy
00:00:47
environment can throw it about me and
00:00:51
attack your split liberty because if
00:00:55
easy. So there are two million new
00:00:58
infections and we here at the market is
00:01:02
dominated by three layers the five at
00:01:06
or so there learned quite a lot of
00:01:08
money but the last you know drop
00:01:12
everything should use its back in two
00:01:13
thousand and two that's fourteen years
00:01:15
ago. And since then with this since I
00:01:18
started to develop. And today we are
00:01:20
facing to Teller to raise of fifty
00:01:22
percent. So we are developing an normal
00:01:26
lot of final call eighty two wait for
00:01:29
this last compound is effective against
00:01:33
be resistant strains if you say well
00:01:35
tolerated. So we will have this
00:01:38
compound develop increase mortality and
00:01:41
it's some ability in actions. So you're
00:01:44
offering USB investment opportunity and
00:01:48
with this after we also going to Boston